<DOC>
	<DOCNO>NCT00135161</DOCNO>
	<brief_summary>The purpose trial study fluorodeoxyglucose-positron emission tomography ( FDG-PET ) -based dose escalation use intensity modulate radiation therapy ( IMRT ) .</brief_summary>
	<brief_title>Feasibility Study Incorporating 18F-FDG-PET Imaging Radiotherapy Head Neck Cancer</brief_title>
	<detailed_description>The dose escalation , base FDG-PET signal , incorporate first ten fraction radiotherapeutic treatment . The total amount fraction 32 , equal standard radiotherapeutic treatment type cancer .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Patients proven histological squamous cell carcinoma larynx ( T34 NO Tany N+ ) , hypopharynx , oropharynx Patients undergo surgery primary tumor location Patients Karnofsky performance score 70 % Written inform consent participation trial Other malignancy except nonmelanoma skin cancer Prior irradiation head neck region</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>neoplasm ( squamous cell carcinoma head neck region )</keyword>
</DOC>